Abeona Therapeutics (ABEO) EPS (Weighted Average and Diluted) (2011 - 2026)
Abeona Therapeutics (ABEO) recorded quarterly EPS (Weighted Average and Diluted) of -$0.3 in Q1 2026, up 11.76% quarter-over-quarter from -$0.34 in Q4 2025, and down 25.0% on a YoY basis from -$0.4 in Q1 2025.
Abeona Therapeutics (ABEO) EPS (Weighted Average and Diluted) (2011 - 2026) Analysis & Trends
Abeona Therapeutics' EPS (Weighted Average and Diluted) history runs 9 years deep, the most recent figure standing at -$0.3 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) fell 25.0% year-over-year to -$0.3; the TTM figure through Mar 2026 stood at $0.97 (up 176.38% YoY), while the FY2025 annual figure was $1.01, up 165.16% from the prior year.
- EPS (Weighted Average and Diluted) was -$0.3 for Q1 2026 at Abeona Therapeutics, up from -$0.34 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $1.71 in Q2 2025 to a low of -$1.16 in Q1 2024.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.2 across 5 years, with a median of -$0.32 in 2025.
- The sharpest annual moves came in 2023 and 2025: EPS (Weighted Average and Diluted) slumped 223.08% in 2023, then jumped 757.69% in 2025.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.52 in 2022, then plunged by 223.08% to -$0.64 in 2023, then surged by 78.12% to -$0.14 in 2024, then sank by 142.86% to -$0.34 in 2025, then advanced by 11.76% to -$0.3 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.3 (Q1 2026), -$0.34 (Q4 2025), and -$0.1 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 0.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -0.61 |
| 10 | Abeona Therapeutics | 309.15 Mn | 140.88 Mn | 6.02 Mn | -0.30 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.30 |
| Dec 31, 2025 | -0.34 |
| Sep 30, 2025 | -0.10 |
| Jun 30, 2025 | 1.71 |
| Mar 31, 2025 | -0.24 |
| Dec 31, 2024 | -0.14 |
| Sep 30, 2024 | -0.63 |
| Jun 30, 2024 | -0.26 |
| Mar 31, 2024 | -1.16 |
| Dec 31, 2023 | -0.64 |
| Sep 30, 2023 | -0.48 |
| Jun 30, 2023 | -0.92 |
| Mar 31, 2023 | -0.54 |
| Dec 31, 2022 | 0.52 |
| Sep 30, 2022 | -1.00 |
| Jun 30, 2022 | 1.36 |
| Dec 31, 2014 | 17.20 |
| Sep 30, 2014 | -4.15 |
| Jun 30, 2014 | -0.51 |
| Mar 31, 2014 | -0.03 |